ZELAPAR (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the ZELAPAR drug offered from Valeant Pharmaceuticals North America LLC. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
| NON-PROPRIETARY NAME: | SELEGILINE HYDROCHLORIDE |
| SUBSTANCE NAME: | SELEGILINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, ORALLY DISINTEGRATING |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-06-14 |
| END MARKETING DATE: | 0000-00-00 |
ZELAPAR HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZELAPAR from Valeant Pharmaceuticals North America LLC |
| LABELER NAME: | Valeant Pharmaceuticals North America LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.25(mg/1) |
| START MARKETING DATE: | 2006-06-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0187-0453_610b4af7-d74b-4e6f-ad01-e869b4352fbb |
| PRODUCT NDC: | 0187-0453 |
| APPLICATION NUMBER: | NDA021479 |
Other SELEGILINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
